Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kent Hutchison to Marijuana Abuse

This is a "connection" page, showing publications Kent Hutchison has written about Marijuana Abuse.

 
Connection Strength
 
 
 
2.856
 
  1. Hagerty SL, YorkWilliams SL, Bidwell LC, Weiland BJ, Sabbineni A, Blaine SK, Bryan AD, Hutchison KE. DRD2 methylation is associated with executive control network connectivity and severity of alcohol problems among a sample of polysubstance users. Addict Biol. 2020 01; 25(1):e12684.
    View in: PubMed
    Score: 0.496
  2. Thayer RE, YorkWilliams S, Karoly HC, Sabbineni A, Ewing SF, Bryan AD, Hutchison KE. Structural neuroimaging correlates of alcohol and cannabis use in adolescents and adults. Addiction. 2017 Dec; 112(12):2144-2154.
    View in: PubMed
    Score: 0.455
  3. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE. Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacology. 2010 Mar; 35(4):967-75.
    View in: PubMed
    Score: 0.268
  4. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE. Marijuana craving in the brain. Proc Natl Acad Sci U S A. 2009 Aug 04; 106(31):13016-21.
    View in: PubMed
    Score: 0.261
  5. Schacht JP, Selling RE, Hutchison KE. Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis. Psychopharmacology (Berl). 2009 Apr; 203(3):511-7.
    View in: PubMed
    Score: 0.249
  6. Haughey HM, Marshall E, Schacht JP, Louis A, Hutchison KE. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction. 2008 Oct; 103(10):1678-86.
    View in: PubMed
    Score: 0.245
  7. Bidwell LC, Martin-Willett R, Melendez SN, Rosa L, Giordano G, Hutchison KE, Bryan AD. LOTUS: Protocol for a double-blind placebo controlled randomized trial of hemp-derived cannabidiol for the treatment of cannabis use disorder. PLoS One. 2024; 19(9):e0308262.
    View in: PubMed
    Score: 0.187
  8. Kulkarni KR, Schafer M, Berner LA, Fiore VG, Heflin M, Hutchison K, Calhoun V, Filbey F, Pandey G, Schiller D, Gu X. An Interpretable and Predictive Connectivity-Based Neural Signature for?Chronic?Cannabis Use. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 03; 8(3):320-330.
    View in: PubMed
    Score: 0.159
  9. Ellingson JM, Bidwell LC, Hopfer CJ, Hutchison KE, Bryan AD. Correlates and Potential Confounds of Cannabis Withdrawal Among High-Risk Adolescents. J Stud Alcohol Drugs. 2019 09; 80(5):557-562.
    View in: PubMed
    Score: 0.132
  10. Henry EA, Kaye JT, Bryan AD, Hutchison KE, Ito TA. Cannabis cue reactivity and craving among never, infrequent and heavy cannabis users. Neuropsychopharmacology. 2014 Apr; 39(5):1214-21.
    View in: PubMed
    Score: 0.088
  11. Feldstein Ewing SW, Mead HK, Yezhuvath U, Dewitt S, Hutchison KE, Filbey FM. A preliminary examination of how serotonergic polymorphisms influence brain response following an adolescent cannabis intervention. Psychiatry Res. 2012 Nov 30; 204(2-3):112-6.
    View in: PubMed
    Score: 0.082
  12. Feldstein Ewing SW, McEachern AD, Yezhuvath U, Bryan AD, Hutchison KE, Filbey FM. Integrating brain and behavior: evaluating adolescents' response to a cannabis intervention. Psychol Addict Behav. 2013 Jun; 27(2):510-25.
    View in: PubMed
    Score: 0.081
  13. Schacht JP, Hutchison KE, Filbey FM. Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacology. 2012 Oct; 37(11):2368-76.
    View in: PubMed
    Score: 0.080
  14. Mackey S, Allgaier N, Chaarani B, Spechler P, Orr C, Bunn J, Allen NB, Alia-Klein N, Batalla A, Blaine S, Brooks S, Caparelli E, Chye YY, Cousijn J, Dagher A, Desrivieres S, Feldstein-Ewing S, Foxe JJ, Goldstein RZ, Goudriaan AE, Heitzeg MM, Hester R, Hutchison K, Korucuoglu O, Li CR, London E, Lorenzetti V, Luijten M, Martin-Santos R, May A, Momenan R, Morales A, Paulus MP, Pearlson G, Rousseau ME, Salmeron BJ, Schluter R, Schmaal L, Schumann G, Sjoerds Z, Stein DJ, Stein EA, Sinha R, Solowij N, Tapert S, Uhlmann A, Veltman D, van Holst R, Whittle S, Wright MJ, Y?cel M, Zhang S, Yurgelun-Todd D, Hibar DP, Jahanshad N, Evans A, Thompson PM, Glahn DC, Conrod P, Garavan H. Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects. Am J Psychiatry. 2019 02 01; 176(2):119-128.
    View in: PubMed
    Score: 0.031
  15. Claus ED, Feldstein Ewing SW, Magnan RE, Montanaro E, Hutchison KE, Bryan AD. Neural mechanisms of risky decision making in adolescents reporting frequent alcohol and/or marijuana use. Brain Imaging Behav. 2018 Apr; 12(2):564-576.
    View in: PubMed
    Score: 0.030
  16. Helstrom A, Bryan A, Hutchison KE, Riggs PD, Blechman EA. Tobacco and alcohol use as an explanation for the association between externalizing behavior and illicit drug use among delinquent adolescents. Prev Sci. 2004 Dec; 5(4):267-77.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)